Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
International Cartilage Repair Society Symposia To Highlight Early Findings Of Prochondrix Cartilage Restoration Matrix | ||
By: PR Newswire Association LLC. - 23 Sep 2016 | Back to overview list |
|
CENTENNIAL, Colo., Sept. 23, 2016 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, will share early results of its fresh cartilage allograft, ProChondrix® Cartilage Restoration Matrix during the International Cartilage Repair Society's (ICRS) 13th World Congress in Sorrento-Naples, Italy. The Industry Satellite Lunch Symposia will take place on Monday, 26 September 2016 from 13:00 to 13:30 in the Sala Nettuna Room. Vishal Mehta, M.D., orthopedic surgeon from Fox Valley Orthopedics in Geneva, Illinois, will present early results of ProChondrix transplantation on isolated articular cartilage defects. Patients underwent treatment of an isolated, symptomatic articular cartilage surface lesion, which was treated with microfracture and placement of a ProChondrix graft. The 12-month review post-treatment demonstrated early success and no failures. In addition to Dr. Mehta, Laurie Goodrich, D.V.M, Ph. D., associate professor in equine surgery and lameness at Colorado State University, will share the findings of a 12-month horse study. "Clinical information is an important piece of the puzzle when finding products to help heal my patients," said Dr. Vishal Mehta, orthopedic surgeon. "I am excited by the promising early results of my first patients who received ProChondrix." AlloSource will also present several posters at ICRS. One will focus on Dr. Mehta's 12-month clinical results, another highlights Dr. Goodrich's equine study findings, both previously mentioned, and another poster shares results from an internal study on ProChondrix's likeness to healthy adult cartilage. The internal study found ProChondrix, a fresh cartilage allograft, inherently matches the biomechanical and biochemical properties of normal hyaline cartilage found in a healthy adult, proving it is a viable solution to help restore articular cartilage surfaces, relieve patient symptoms and improve function. For more information on ProChondrix and the recently launched Reimbursement Hotline dedicated to assisting customers and providing information on coding options, coverage access and reimbursement, please visit ProChondrix.org. About AlloSource Media Contact
SOURCE AlloSource |
||
|
||
Copyright 2016 PR Newswire Association LLC. | Back to overview list |